nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—HRH1—atherosclerosis	0.84	1	CbGaD
Betahistine—Orthostatic hypotension—Niacin—atherosclerosis	0.0012	0.0134	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00117	0.013	CcSEcCtD
Betahistine—Abdominal distension—Niacin—atherosclerosis	0.00114	0.0128	CcSEcCtD
Betahistine—Abdominal distension—Pravastatin—atherosclerosis	0.00113	0.0126	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00109	0.0122	CcSEcCtD
Betahistine—Flatulence—Rosuvastatin—atherosclerosis	0.00107	0.0119	CcSEcCtD
Betahistine—Erythema multiforme—Lovastatin—atherosclerosis	0.001	0.0112	CcSEcCtD
Betahistine—Angioedema—Rosuvastatin—atherosclerosis	0.000995	0.0111	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00099	0.011	CcSEcCtD
Betahistine—Erythema multiforme—Ezetimibe—atherosclerosis	0.000983	0.0109	CcSEcCtD
Betahistine—Immune system disorder—Ezetimibe—atherosclerosis	0.000939	0.0105	CcSEcCtD
Betahistine—Erythema multiforme—Simvastatin—atherosclerosis	0.000937	0.0104	CcSEcCtD
Betahistine—Flatulence—Lovastatin—atherosclerosis	0.000909	0.0101	CcSEcCtD
Betahistine—Confusional state—Rosuvastatin—atherosclerosis	0.000896	0.00998	CcSEcCtD
Betahistine—Flatulence—Ezetimibe—atherosclerosis	0.000892	0.00993	CcSEcCtD
Betahistine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000871	0.0097	CcSEcCtD
Betahistine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000856	0.00953	CcSEcCtD
Betahistine—Flatulence—Simvastatin—atherosclerosis	0.00085	0.00947	CcSEcCtD
Betahistine—Erythema multiforme—Pravastatin—atherosclerosis	0.000847	0.00944	CcSEcCtD
Betahistine—Angioedema—Lovastatin—atherosclerosis	0.000843	0.00939	CcSEcCtD
Betahistine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00084	0.00935	CcSEcCtD
Betahistine—Malaise—Lovastatin—atherosclerosis	0.000832	0.00927	CcSEcCtD
Betahistine—Angioedema—Ezetimibe—atherosclerosis	0.000827	0.00921	CcSEcCtD
Betahistine—Malaise—Ezetimibe—atherosclerosis	0.000816	0.00909	CcSEcCtD
Betahistine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000801	0.00892	CcSEcCtD
Betahistine—Angioedema—Simvastatin—atherosclerosis	0.000789	0.00878	CcSEcCtD
Betahistine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000782	0.00871	CcSEcCtD
Betahistine—Flatulence—Niacin—atherosclerosis	0.000781	0.0087	CcSEcCtD
Betahistine—Malaise—Simvastatin—atherosclerosis	0.000778	0.00867	CcSEcCtD
Betahistine—Discomfort—Lovastatin—atherosclerosis	0.000776	0.00864	CcSEcCtD
Betahistine—Flatulence—Pravastatin—atherosclerosis	0.000769	0.00856	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000765	0.00852	CcSEcCtD
Betahistine—Discomfort—Ezetimibe—atherosclerosis	0.000761	0.00848	CcSEcCtD
Betahistine—Confusional state—Lovastatin—atherosclerosis	0.000759	0.00846	CcSEcCtD
Betahistine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000753	0.00839	CcSEcCtD
Betahistine—Confusional state—Ezetimibe—atherosclerosis	0.000745	0.00829	CcSEcCtD
Betahistine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000739	0.00823	CcSEcCtD
Betahistine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000732	0.00816	CcSEcCtD
Betahistine—Discomfort—Simvastatin—atherosclerosis	0.000726	0.00809	CcSEcCtD
Betahistine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000724	0.00807	CcSEcCtD
Betahistine—Angioedema—Niacin—atherosclerosis	0.000724	0.00806	CcSEcCtD
Betahistine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000724	0.00806	CcSEcCtD
Betahistine—Skin disorder—Ezetimibe—atherosclerosis	0.000717	0.00799	CcSEcCtD
Betahistine—Angioedema—Pravastatin—atherosclerosis	0.000713	0.00794	CcSEcCtD
Betahistine—Confusional state—Simvastatin—atherosclerosis	0.00071	0.00791	CcSEcCtD
Betahistine—Urticaria—Rosuvastatin—atherosclerosis	0.000706	0.00786	CcSEcCtD
Betahistine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000704	0.00784	CcSEcCtD
Betahistine—Malaise—Pravastatin—atherosclerosis	0.000704	0.00784	CcSEcCtD
Betahistine—Dyspnoea—Lovastatin—atherosclerosis	0.000671	0.00748	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00067	0.00746	CcSEcCtD
Betahistine—Dyspepsia—Lovastatin—atherosclerosis	0.000663	0.00738	CcSEcCtD
Betahistine—Dyspnoea—Ezetimibe—atherosclerosis	0.000658	0.00733	CcSEcCtD
Betahistine—Discomfort—Pravastatin—atherosclerosis	0.000656	0.00731	CcSEcCtD
Betahistine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000655	0.00729	CcSEcCtD
Betahistine—Dyspepsia—Ezetimibe—atherosclerosis	0.00065	0.00724	CcSEcCtD
Betahistine—Fatigue—Lovastatin—atherosclerosis	0.000649	0.00723	CcSEcCtD
Betahistine—Anaphylactic shock—Niacin—atherosclerosis	0.000647	0.0072	CcSEcCtD
Betahistine—Confusional state—Pravastatin—atherosclerosis	0.000642	0.00715	CcSEcCtD
Betahistine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000638	0.0071	CcSEcCtD
Betahistine—Asthenia—Rosuvastatin—atherosclerosis	0.000637	0.0071	CcSEcCtD
Betahistine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000637	0.00709	CcSEcCtD
Betahistine—Fatigue—Ezetimibe—atherosclerosis	0.000637	0.00709	CcSEcCtD
Betahistine—Tachycardia—Niacin—atherosclerosis	0.000631	0.00703	CcSEcCtD
Betahistine—Pruritus—Rosuvastatin—atherosclerosis	0.000629	0.007	CcSEcCtD
Betahistine—Skin disorder—Niacin—atherosclerosis	0.000628	0.007	CcSEcCtD
Betahistine—Dyspnoea—Simvastatin—atherosclerosis	0.000628	0.00699	CcSEcCtD
Betahistine—Feeling abnormal—Lovastatin—atherosclerosis	0.00062	0.00691	CcSEcCtD
Betahistine—Dyspepsia—Simvastatin—atherosclerosis	0.00062	0.00691	CcSEcCtD
Betahistine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000609	0.00678	CcSEcCtD
Betahistine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000608	0.00677	CcSEcCtD
Betahistine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000608	0.00677	CcSEcCtD
Betahistine—Fatigue—Simvastatin—atherosclerosis	0.000607	0.00676	CcSEcCtD
Betahistine—Urticaria—Lovastatin—atherosclerosis	0.000598	0.00666	CcSEcCtD
Betahistine—Dizziness—Rosuvastatin—atherosclerosis	0.000588	0.00654	CcSEcCtD
Betahistine—Urticaria—Ezetimibe—atherosclerosis	0.000587	0.00653	CcSEcCtD
Betahistine—Feeling abnormal—Simvastatin—atherosclerosis	0.00058	0.00646	CcSEcCtD
Betahistine—Dyspnoea—Niacin—atherosclerosis	0.000577	0.00642	CcSEcCtD
Betahistine—Somnolence—Niacin—atherosclerosis	0.000575	0.0064	CcSEcCtD
Betahistine—Dyspepsia—Niacin—atherosclerosis	0.000569	0.00634	CcSEcCtD
Betahistine—Dyspnoea—Pravastatin—atherosclerosis	0.000568	0.00632	CcSEcCtD
Betahistine—Dyspepsia—Pravastatin—atherosclerosis	0.00056	0.00624	CcSEcCtD
Betahistine—Rash—Rosuvastatin—atherosclerosis	0.00056	0.00624	CcSEcCtD
Betahistine—Dermatitis—Rosuvastatin—atherosclerosis	0.00056	0.00623	CcSEcCtD
Betahistine—Urticaria—Simvastatin—atherosclerosis	0.00056	0.00623	CcSEcCtD
Betahistine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000558	0.00622	CcSEcCtD
Betahistine—Headache—Rosuvastatin—atherosclerosis	0.000557	0.0062	CcSEcCtD
Betahistine—Hypersensitivity—Lovastatin—atherosclerosis	0.000555	0.00618	CcSEcCtD
Betahistine—Fatigue—Pravastatin—atherosclerosis	0.000549	0.00611	CcSEcCtD
Betahistine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000544	0.00606	CcSEcCtD
Betahistine—Asthenia—Lovastatin—atherosclerosis	0.00054	0.00602	CcSEcCtD
Betahistine—Pruritus—Lovastatin—atherosclerosis	0.000533	0.00593	CcSEcCtD
Betahistine—Asthenia—Ezetimibe—atherosclerosis	0.00053	0.0059	CcSEcCtD
Betahistine—Nausea—Rosuvastatin—atherosclerosis	0.000528	0.00588	CcSEcCtD
Betahistine—Feeling abnormal—Pravastatin—atherosclerosis	0.000525	0.00584	CcSEcCtD
Betahistine—Pruritus—Ezetimibe—atherosclerosis	0.000523	0.00582	CcSEcCtD
Betahistine—Hypersensitivity—Simvastatin—atherosclerosis	0.000519	0.00578	CcSEcCtD
Betahistine—Diarrhoea—Lovastatin—atherosclerosis	0.000515	0.00574	CcSEcCtD
Betahistine—Urticaria—Niacin—atherosclerosis	0.000514	0.00572	CcSEcCtD
Betahistine—Urticaria—Pravastatin—atherosclerosis	0.000506	0.00563	CcSEcCtD
Betahistine—Asthenia—Simvastatin—atherosclerosis	0.000505	0.00563	CcSEcCtD
Betahistine—Diarrhoea—Ezetimibe—atherosclerosis	0.000505	0.00563	CcSEcCtD
Betahistine—Pruritus—Simvastatin—atherosclerosis	0.000498	0.00555	CcSEcCtD
Betahistine—Dizziness—Lovastatin—atherosclerosis	0.000498	0.00555	CcSEcCtD
Betahistine—Dizziness—Ezetimibe—atherosclerosis	0.000488	0.00544	CcSEcCtD
Betahistine—Diarrhoea—Simvastatin—atherosclerosis	0.000482	0.00537	CcSEcCtD
Betahistine—Vomiting—Lovastatin—atherosclerosis	0.000479	0.00533	CcSEcCtD
Betahistine—Hypersensitivity—Niacin—atherosclerosis	0.000476	0.00531	CcSEcCtD
Betahistine—Rash—Lovastatin—atherosclerosis	0.000475	0.00529	CcSEcCtD
Betahistine—Dermatitis—Lovastatin—atherosclerosis	0.000474	0.00528	CcSEcCtD
Betahistine—Headache—Lovastatin—atherosclerosis	0.000472	0.00525	CcSEcCtD
Betahistine—Vomiting—Ezetimibe—atherosclerosis	0.00047	0.00523	CcSEcCtD
Betahistine—Hypersensitivity—Pravastatin—atherosclerosis	0.000469	0.00523	CcSEcCtD
Betahistine—Dizziness—Simvastatin—atherosclerosis	0.000466	0.00519	CcSEcCtD
Betahistine—Rash—Ezetimibe—atherosclerosis	0.000466	0.00519	CcSEcCtD
Betahistine—Dermatitis—Ezetimibe—atherosclerosis	0.000465	0.00518	CcSEcCtD
Betahistine—Asthenia—Niacin—atherosclerosis	0.000464	0.00517	CcSEcCtD
Betahistine—Headache—Ezetimibe—atherosclerosis	0.000463	0.00515	CcSEcCtD
Betahistine—Pruritus—Niacin—atherosclerosis	0.000458	0.0051	CcSEcCtD
Betahistine—Asthenia—Pravastatin—atherosclerosis	0.000457	0.00509	CcSEcCtD
Betahistine—Pruritus—Pravastatin—atherosclerosis	0.00045	0.00502	CcSEcCtD
Betahistine—Vomiting—Simvastatin—atherosclerosis	0.000448	0.00499	CcSEcCtD
Betahistine—Nausea—Lovastatin—atherosclerosis	0.000447	0.00498	CcSEcCtD
Betahistine—Rash—Simvastatin—atherosclerosis	0.000444	0.00495	CcSEcCtD
Betahistine—Dermatitis—Simvastatin—atherosclerosis	0.000444	0.00494	CcSEcCtD
Betahistine—Diarrhoea—Niacin—atherosclerosis	0.000442	0.00493	CcSEcCtD
Betahistine—Headache—Simvastatin—atherosclerosis	0.000441	0.00491	CcSEcCtD
Betahistine—Nausea—Ezetimibe—atherosclerosis	0.000439	0.00489	CcSEcCtD
Betahistine—Diarrhoea—Pravastatin—atherosclerosis	0.000436	0.00485	CcSEcCtD
Betahistine—Dizziness—Niacin—atherosclerosis	0.000428	0.00476	CcSEcCtD
Betahistine—Dizziness—Pravastatin—atherosclerosis	0.000421	0.00469	CcSEcCtD
Betahistine—Nausea—Simvastatin—atherosclerosis	0.000418	0.00466	CcSEcCtD
Betahistine—Vomiting—Niacin—atherosclerosis	0.000411	0.00458	CcSEcCtD
Betahistine—Rash—Niacin—atherosclerosis	0.000408	0.00454	CcSEcCtD
Betahistine—Dermatitis—Niacin—atherosclerosis	0.000407	0.00454	CcSEcCtD
Betahistine—Headache—Niacin—atherosclerosis	0.000405	0.00451	CcSEcCtD
Betahistine—Vomiting—Pravastatin—atherosclerosis	0.000405	0.00451	CcSEcCtD
Betahistine—Rash—Pravastatin—atherosclerosis	0.000401	0.00447	CcSEcCtD
Betahistine—Dermatitis—Pravastatin—atherosclerosis	0.000401	0.00447	CcSEcCtD
Betahistine—Headache—Pravastatin—atherosclerosis	0.000399	0.00444	CcSEcCtD
Betahistine—Nausea—Niacin—atherosclerosis	0.000384	0.00428	CcSEcCtD
Betahistine—Nausea—Pravastatin—atherosclerosis	0.000378	0.00421	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—CX3CL1—atherosclerosis	0.00018	0.00255	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRH1—atherosclerosis	0.000175	0.00249	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CNR2—atherosclerosis	0.00017	0.00242	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—EDNRA—atherosclerosis	0.000169	0.0024	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.000168	0.00239	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000167	0.00237	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000166	0.00236	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—GHRL—atherosclerosis	0.000165	0.00234	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000161	0.00229	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—NFKB1—atherosclerosis	0.000159	0.00226	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000155	0.0022	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—AGT—atherosclerosis	0.000154	0.00219	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000152	0.00216	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.000151	0.00215	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.000147	0.00209	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL3—atherosclerosis	0.000146	0.00208	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCR2—atherosclerosis	0.000146	0.00207	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—EDNRA—atherosclerosis	0.000146	0.00207	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—KNG1—atherosclerosis	0.000145	0.00205	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.000144	0.00204	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—AGTR1—atherosclerosis	0.000144	0.00204	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—STAT3—atherosclerosis	0.000143	0.00203	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—F2—atherosclerosis	0.000143	0.00203	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—GHRL—atherosclerosis	0.000142	0.00202	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL4—atherosclerosis	0.000138	0.00196	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOA4—atherosclerosis	0.000137	0.00195	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—MAPK3—atherosclerosis	0.000137	0.00194	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCR2—atherosclerosis	0.000132	0.00188	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EDNRA—atherosclerosis	0.000132	0.00188	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000132	0.00188	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000131	0.00186	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000131	0.00186	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.000129	0.00184	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—GHRL—atherosclerosis	0.000129	0.00183	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.000128	0.00183	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCL2—atherosclerosis	0.000127	0.00181	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL4—atherosclerosis	0.000127	0.0018	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—KNG1—atherosclerosis	0.000125	0.00177	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGTR1—atherosclerosis	0.000124	0.00176	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000124	0.00176	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—UTS2—atherosclerosis	0.000123	0.00175	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—EDN1—atherosclerosis	0.000122	0.00173	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOA2—atherosclerosis	0.000118	0.00168	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CX3CR1—atherosclerosis	0.000118	0.00167	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CASR—atherosclerosis	0.000118	0.00167	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000116	0.00164	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.000115	0.00163	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KNG1—atherosclerosis	0.000113	0.00161	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—UTS2—atherosclerosis	0.000113	0.0016	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGTR1—atherosclerosis	0.000113	0.0016	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000112	0.00159	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000112	0.00159	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000111	0.00158	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CNR2—atherosclerosis	0.00011	0.00156	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000109	0.00155	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.000109	0.00155	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CX3CR1—atherosclerosis	0.000108	0.00154	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASR—atherosclerosis	0.000108	0.00154	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CX3CL1—atherosclerosis	0.000106	0.00151	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—EDN1—atherosclerosis	0.000105	0.00149	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCL5—atherosclerosis	0.000104	0.00148	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—AGT—atherosclerosis	0.000101	0.00144	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CNR2—atherosclerosis	0.000101	0.00143	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCL8—atherosclerosis	0.0001	0.00143	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MMP3—atherosclerosis	0.0001	0.00143	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PRKCG—atherosclerosis	9.91e-05	0.00141	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	9.57e-05	0.00136	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EDN1—atherosclerosis	9.54e-05	0.00136	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	9.51e-05	0.00135	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL5—atherosclerosis	9.47e-05	0.00135	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL3—atherosclerosis	9.42e-05	0.00134	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—F2—atherosclerosis	9.34e-05	0.00133	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—AKT1—atherosclerosis	9.21e-05	0.00131	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	9.04e-05	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PRKCG—atherosclerosis	9e-05	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VWF—atherosclerosis	8.96e-05	0.00127	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOC3—atherosclerosis	8.91e-05	0.00127	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LDLR—atherosclerosis	8.85e-05	0.00126	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGT—atherosclerosis	8.72e-05	0.00124	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL3—atherosclerosis	8.65e-05	0.00123	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—EDNRA—atherosclerosis	8.52e-05	0.00121	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR2—atherosclerosis	8.52e-05	0.00121	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	8.35e-05	0.00119	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GHRL—atherosclerosis	8.3e-05	0.00118	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NCF1—atherosclerosis	8.28e-05	0.00118	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	8.07e-05	0.00115	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—F2—atherosclerosis	8.06e-05	0.00115	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	8e-05	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGT—atherosclerosis	7.92e-05	0.00113	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EDNRA—atherosclerosis	7.82e-05	0.00111	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR2—atherosclerosis	7.82e-05	0.00111	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CYBA—atherosclerosis	7.79e-05	0.00111	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CG—atherosclerosis	7.71e-05	0.0011	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GHRL—atherosclerosis	7.62e-05	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PARP1—atherosclerosis	7.62e-05	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PLAT—atherosclerosis	7.62e-05	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—F2—atherosclerosis	7.32e-05	0.00104	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—KNG1—atherosclerosis	7.29e-05	0.00104	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGTR1—atherosclerosis	7.25e-05	0.00103	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL4—atherosclerosis	7.08e-05	0.00101	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CG—atherosclerosis	7e-05	0.000995	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—UTS2—atherosclerosis	6.95e-05	0.000987	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	6.7e-05	0.000951	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KNG1—atherosclerosis	6.69e-05	0.00095	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CASR—atherosclerosis	6.66e-05	0.000946	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGTR1—atherosclerosis	6.65e-05	0.000945	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL2—atherosclerosis	6.52e-05	0.000927	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PLG—atherosclerosis	6.48e-05	0.000921	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—UTS2—atherosclerosis	6.31e-05	0.000896	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CNR2—atherosclerosis	6.19e-05	0.00088	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	6.19e-05	0.000879	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—EDN1—atherosclerosis	6.14e-05	0.000873	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SOCS3—atherosclerosis	6.14e-05	0.000872	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL5—atherosclerosis	6.1e-05	0.000866	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CX3CR1—atherosclerosis	6.05e-05	0.000859	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CASR—atherosclerosis	6.05e-05	0.000859	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CX3CL1—atherosclerosis	5.93e-05	0.000843	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP3—atherosclerosis	5.93e-05	0.000842	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF2—atherosclerosis	5.9e-05	0.000838	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOB—atherosclerosis	5.73e-05	0.000814	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL8—atherosclerosis	5.68e-05	0.000807	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EDN1—atherosclerosis	5.64e-05	0.000801	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CNR2—atherosclerosis	5.62e-05	0.000799	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL5—atherosclerosis	5.59e-05	0.000795	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	5.51e-05	0.000784	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LPL—atherosclerosis	5.47e-05	0.000777	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCG—atherosclerosis	5.32e-05	0.000756	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SPP1—atherosclerosis	5.18e-05	0.000736	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL8—atherosclerosis	5.16e-05	0.000733	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGT—atherosclerosis	5.1e-05	0.000724	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL3—atherosclerosis	4.84e-05	0.000687	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDNRA—atherosclerosis	4.82e-05	0.000684	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR2—atherosclerosis	4.82e-05	0.000684	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDGFB—atherosclerosis	4.79e-05	0.000681	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—F2—atherosclerosis	4.71e-05	0.000669	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GHRL—atherosclerosis	4.69e-05	0.000667	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGT—atherosclerosis	4.68e-05	0.000665	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LEP—atherosclerosis	4.58e-05	0.000651	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOE—atherosclerosis	4.58e-05	0.000651	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CAV1—atherosclerosis	4.54e-05	0.000645	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOA4—atherosclerosis	4.54e-05	0.000645	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOA1—atherosclerosis	4.53e-05	0.000644	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	4.52e-05	0.000643	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ESR1—atherosclerosis	4.38e-05	0.000622	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR2—atherosclerosis	4.37e-05	0.000621	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDNRA—atherosclerosis	4.37e-05	0.000621	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.36e-05	0.000619	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—F2—atherosclerosis	4.32e-05	0.000614	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GHRL—atherosclerosis	4.26e-05	0.000606	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL2—atherosclerosis	4.2e-05	0.000597	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL4—atherosclerosis	4.18e-05	0.000594	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CG—atherosclerosis	4.14e-05	0.000588	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—KNG1—atherosclerosis	4.12e-05	0.000585	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR1—atherosclerosis	4.09e-05	0.000582	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK3—atherosclerosis	3.96e-05	0.000563	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INS—atherosclerosis	3.92e-05	0.000556	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOA2—atherosclerosis	3.91e-05	0.000555	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL2—atherosclerosis	3.85e-05	0.000548	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1—atherosclerosis	3.79e-05	0.000538	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KNG1—atherosclerosis	3.74e-05	0.000531	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—UTS2—atherosclerosis	3.73e-05	0.00053	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR1—atherosclerosis	3.72e-05	0.000528	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SERPINE1—atherosclerosis	3.6e-05	0.000511	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CX3CR1—atherosclerosis	3.57e-05	0.000508	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASR—atherosclerosis	3.57e-05	0.000508	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CX3CL1—atherosclerosis	3.5e-05	0.000498	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDN1—atherosclerosis	3.47e-05	0.000493	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCL5—atherosclerosis	3.44e-05	0.000489	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOS3—atherosclerosis	3.43e-05	0.000488	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CNR2—atherosclerosis	3.32e-05	0.000472	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL8—atherosclerosis	3.32e-05	0.000472	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MMP3—atherosclerosis	3.31e-05	0.000471	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	3.31e-05	0.00047	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PRKCG—atherosclerosis	3.27e-05	0.000465	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDN1—atherosclerosis	3.15e-05	0.000448	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL5—atherosclerosis	3.13e-05	0.000444	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL8—atherosclerosis	3.05e-05	0.000433	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKCG—atherosclerosis	2.97e-05	0.000423	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VWF—atherosclerosis	2.96e-05	0.000421	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—atherosclerosis	2.94e-05	0.000418	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOC3—atherosclerosis	2.94e-05	0.000418	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LDLR—atherosclerosis	2.92e-05	0.000416	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—atherosclerosis	2.9e-05	0.000412	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGT—atherosclerosis	2.88e-05	0.000409	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL3—atherosclerosis	2.86e-05	0.000406	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—atherosclerosis	2.76e-05	0.000392	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NCF1—atherosclerosis	2.74e-05	0.000389	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NFKB1—atherosclerosis	2.73e-05	0.000387	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK8—atherosclerosis	2.68e-05	0.000381	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—atherosclerosis	2.67e-05	0.00038	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—F2—atherosclerosis	2.66e-05	0.000378	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGT—atherosclerosis	2.62e-05	0.000372	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR2—atherosclerosis	2.58e-05	0.000367	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDNRA—atherosclerosis	2.58e-05	0.000367	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CYBA—atherosclerosis	2.57e-05	0.000365	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.55e-05	0.000362	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GHRL—atherosclerosis	2.52e-05	0.000358	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PARP1—atherosclerosis	2.52e-05	0.000358	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLAT—atherosclerosis	2.52e-05	0.000358	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—atherosclerosis	2.47e-05	0.000352	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—atherosclerosis	2.45e-05	0.000348	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—F2—atherosclerosis	2.42e-05	0.000344	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK3—atherosclerosis	2.34e-05	0.000333	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	2.31e-05	0.000329	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—atherosclerosis	2.27e-05	0.000323	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KNG1—atherosclerosis	2.21e-05	0.000314	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	2.2e-05	0.000312	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	2.15e-05	0.000306	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLG—atherosclerosis	2.14e-05	0.000304	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	2.03e-05	0.000288	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP3—atherosclerosis	1.96e-05	0.000278	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF2—atherosclerosis	1.95e-05	0.000277	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOB—atherosclerosis	1.89e-05	0.000269	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	1.88e-05	0.000267	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDN1—atherosclerosis	1.86e-05	0.000265	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL5—atherosclerosis	1.85e-05	0.000263	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LPL—atherosclerosis	1.81e-05	0.000257	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	1.76e-05	0.00025	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—atherosclerosis	1.71e-05	0.000243	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SPP1—atherosclerosis	1.71e-05	0.000243	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	1.7e-05	0.000242	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	1.58e-05	0.000225	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—atherosclerosis	1.58e-05	0.000224	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGT—atherosclerosis	1.55e-05	0.00022	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOE—atherosclerosis	1.51e-05	0.000215	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEP—atherosclerosis	1.51e-05	0.000215	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CAV1—atherosclerosis	1.5e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOA1—atherosclerosis	1.5e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ESR1—atherosclerosis	1.45e-05	0.000205	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—F2—atherosclerosis	1.43e-05	0.000203	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	1.37e-05	0.000194	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	1.31e-05	0.000186	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INS—atherosclerosis	1.29e-05	0.000184	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL2—atherosclerosis	1.27e-05	0.000181	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1—atherosclerosis	1.25e-05	0.000178	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	1.19e-05	0.000169	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOS3—atherosclerosis	1.13e-05	0.000161	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	1.01e-05	0.000143	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	9.72e-06	0.000138	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—atherosclerosis	9.57e-06	0.000136	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—atherosclerosis	9.1e-06	0.000129	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	9.01e-06	0.000128	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	8.85e-06	0.000126	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	8.83e-06	0.000125	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	8.17e-06	0.000116	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—atherosclerosis	8.09e-06	0.000115	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	7.73e-06	0.00011	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	7.5e-06	0.000107	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—atherosclerosis	5.65e-06	8.03e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—atherosclerosis	5.22e-06	7.41e-05	CbGpPWpGaD
